Skip to main content

Pasithea Therapeutics Corp.

KTTAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001841330

No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $3.18K in total; no superinvestor holds it.

Other share classesKTTA

13F holders, Q2 2026

Institutional positions in Pasithea Therapeutics Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
6
+1 vs. Q1 2026
Shares held
491.8K
+11.6K (+2.4%) vs. Q1 2026
Total value
$3.18K
−$2.34K (−42.3%) vs. Q1 2026
New holders
2
1 more added
Sold out
1
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KTTAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 6 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 3 institutionsQ4 2021: 4 institutionsQ1 2022: 4 institutionsQ2 2022: 5 institutionsQ3 2022: 5 institutionsQ4 2022: 3 institutionsQ1 2023: 2 institutionsQ2 2023: 5 institutionsQ3 2023: 7 institutionsQ4 2023: 5 institutionsQ1 2024: 6 institutionsQ2 2024: 6 institutionsQ3 2024: 5 institutionsQ4 2024: 5 institutionsQ1 2025: 6 institutionsQ2 2025: 5 institutionsQ3 2025: 5 institutionsQ4 2025: 4 institutionsQ1 2026: 5 institutionsQ2 2026: 6 institutions
Value heldQ2 2026: $3.18K
Q1 2021: $0Q2 2021: $0Q3 2021: $1.12MQ4 2021: $579.0KQ1 2022: $278.0KQ2 2022: $108.0KQ3 2022: $240.0KQ4 2022: $49.6KQ1 2023: $48.7KQ2 2023: $27.0KQ3 2023: $13.2KQ4 2023: $29.9KQ1 2024: $8.68KQ2 2024: $12.7KQ3 2024: $23.8KQ4 2024: $23.5KQ1 2025: $9.59KQ2 2025: $8.80KQ3 2025: $7.72KQ4 2025: $6.83KQ1 2026: $5.52KQ2 2026: $3.18K
Institutions holding KTTAW and their total value by quarter
QuarterHoldersValue
Q2 20266$3.18K
Q1 20265$5.52K
Q4 20254$6.83K
Q3 20255$7.72K
Q2 20255$8.80K
Q1 20256$9.59K
Q4 20245$23.5K
Q3 20245$23.8K
Q2 20246$12.7K
Q1 20246$8.68K
Q4 20235$29.9K
Q3 20237$13.2K
Q2 20235$27.0K
Q1 20232$48.7K
Q4 20223$49.6K
Q3 20225$240.0K
Q2 20225$108.0K
Q1 20224$278.0K
Q4 20214$579.0K
Q3 20213$1.12M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Pasithea Therapeutics Corp.; share changes are against Q1 2026.

Institutions holding KTTAW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Kepos Capital LP334,600$2.00K0.00%00.0%Unchanged
Two Sigma Securities, LLC57,539$3970.00%+1,895+3.4%Added
Armistice Capital, LLC50,000$3450.00%00.0%Unchanged
Marex Group plc25,000$2230.00%00.0%Unchanged
Susquehanna International Group, LLP24,293$2160.00%+24,293New
Clear Street Group Inc.380$30.00%+380New
Advisor Group Holdings, Inc.0$00.00%−15,000−100.0%Sold out